🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety, immunogenicity,and toler...
Status
Completed
Location
Heartland Research Associates, LLC
Start Date
2010-11
Trial ID
NCT01250795
Treatments Being Tested
The principal objectives of the RADAR trial is to address the hypotheses; 1...
Status
Completed
Location
Campbelltown Hospital
Start Date
2003-10
Trial ID
NCT00193856
Treatments Being Tested
This is a multicenter, double-blinded, randomized, prospective, controlled ...
Status
Completed
Location
United States, Florida
Start Date
2020-10-22
Trial ID
NCT04540913
Treatments Being Tested
The purpose of this study is to investigate the safety and immunogenicity o...
Status
Completed
Location
Meridian Clinical Research
Start Date
2012-05
Trial ID
NCT01612000
Treatments Being Tested
This is a randomized, controlled, double-blinded, within-subject (split-fac...
Status
Completed
Location
California
Start Date
2019-10-30
Trial ID
NCT04069585
Treatments Being Tested
GOIZ ZAINDU ("caring early" in Basque) is a pilot study to adapt the Finnis...
Status
Completed
Location
CITA-alzheimer
Start Date
2018-04-01
Trial ID
NCT06163716
Treatments Being Tested
The purpose of this study was to evaluate a single dose of FluBlok in terms...
Status
Completed
Location
Impact Clinical Trials
Start Date
2007-09-15
Trial ID
NCT00539981
The Teosyal RHA® family of products (RHA® 1, RHA® 2, RHA® 3, and RHA® 4) is...
Status
Unknown
Location
Woodbridge, Ontario Site
Start Date
2021-08-20
Trial ID
NCT04846530
Treatments Being Tested
Flublok was studied previously in children 6 -59 months of age and demonstr...
Status
Completed
Location
Maine Research Associates, LLC
Start Date
2013-11
Trial ID
NCT01959945
Treatments Being Tested
The primary study objectives are: * To demonstrate that a 2-dose regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2007-11-29
Trial ID
NCT00566527
Treatments Being Tested